当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 2018年第7期
编号:13235424
抑制PI3K/Akt信号通路对胶质瘤侵袭性及增殖力的影响(3)
http://www.100md.com 2018年3月5日 《中西医结合心血管病电子杂志》 2018年第7期
     [10]韦鹏翔.中国中西医实用神经外科学[M].2015,北京:中国医药科技出版社,2015:501-520.

    [11]Habberstad AH, Lind-Landstrom T,Sundstorm S,et al.Primary human glioblastomas-prognostic value of clinical and histopathological parameters[J].Clin Neuropathol,2012,31(5):361-368.

    [12]Cheng YK,Beroukhim R,Levine RL,et al.A mathematical methodology for determining the temporal order of pathway alterations arising during glioma- genesis[J].Plos Comput Biol,2012,8(1):e1002.

    [13]Brandes AA,Franceschi E,Tosoni A,et al.Epidermal growth factor receptor inhibitors in neuro-oncoloy:hopes and disappointments[J].Clin Cancer Res,2008,14(4):957-960.

    [14]Micallef J,Taccone M,Mukherjee J,et al.Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression[J].Cancer Res 2009,69(19):7548-7556.

    [15]Hatanpaa KJ,Burma S,Zhao D,et al.Epidermal growth factor receptor in glioma:signal transduction,neuropathology,imaging,and radioresistance[J].Neoplasis,2010,12(9):675-684.

    [16]Chakravarti A,Zhai G, Suzuki Y, et al.The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas[J].J Clin Oncol,2004,22(10):1926-1933.

    [17]董 倫,蒲佩玉,王 虎,等.EGFR反义RNA与p53基因联合转导抑制胶质瘤细胞增殖的体外实验研究[J].中华神经外科杂志,2007,23:678-681.

    本文编辑:吴宏艳, 百拇医药(张振国 贾丽燕 杨廷舰)
上一页1 2 3